Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zachary W. Smith"'
Autor:
April L. Gilbert, Zachary W. Smith, Giacomo Bruno, Pramod N. Nehete, Alessandro Grattoni, Marco Folci, Kathryn A. Shelton, Lorraine R Hill, Jagannadha K. Sastry, Corrine Ying Xuan Chua, Carly S. Filgueira, Keith A. Youker, Priya Jain, Andrea Ballerini, Areeba Ali
Publikováno v:
Biomedical microdevices. 20(2)
With nearly 40% of U.S. adults obese, and childhood and adolescent rates rising, obesity and associated comorbidities are serious public health concerns with massive societal costs. Often, lifestyle interventions do not offer sufficient weight loss t
Autor:
Andrea Ballerini, Giacomo Bruno, Jeremy Ho, R. Lyle Hood, Alessandro Grattoni, Antonia Susnjar, Fernanda P. Pons-Faudoa, Zachary W. Smith, Nicola Di Trani, Antons Sizovs, Priya Jain, Carly S. Filgueira, Corrine Ying Xuan Chua
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine. 16
Globally, 145.2 million people suffer from moderate to severe vision impairment or blindness due to preventable or treatable causes. However, patient adherence to topical or intravitreal treatment is a leading cause of poor outcomes. To address this
Autor:
Giancarlo Canavese, Alberto Pimpinelli, R. Lyle Hood, Giacomo Bruno, Sharath Hosali, Alessandro Grattoni, Carly S. Filgueira, Danilo Demarchi, Priya Jain, Zachary W. Smith, Erika Zabre, Mauro Ferrari, Nicola Di Trani
Publikováno v:
Nature Communications
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Nature Communications, Vol 9, Iss 1, Pp 1-10 (2018)
Ionic transport through nanofluidic systems is a problem of fundamental interest in transport physics and has broad relevance in desalination, fuel cells, batteries, filtration, and drug delivery. When the dimension of the fluidic system approaches t
Autor:
Andrea Ballerini, April L. Gilbert, Carly S. Filgueira, Alessandro Grattoni, Eugenia Nicolov, Zachary W. Smith, Priya Jain, Francesco Scaglione, Corrine Ying Xuan Chua
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine. 13(5)
This study demonstrated a nanochannel membrane device (NMD) for controlled and sustained release of GC-1 in rats, in the context of the treatment of metabolic syndrome. Release profiles were established in vitro both with and without 5% labrasol for